Webinars

Search

Saved Activities

 x 

0 Activities
0 Activities

FDA Criteria: Biosimilar Approval, Manufacturing, & Naming

Array

Activity Info

Upon completion of the activity, participants should be able to explain the data package required by the FDA for biosimilar approval and explain how this differs from a biologic ‘standalone’ development program.
Email

CME/CE credit is no longer available for this activity.

Tags

Webinar | Oncology | 0.25 - 15 mins | Dermatology | Gastroenterology | Hematology | Internal Medicine | Rheumatology | Family Medicine | Nurse | Biosimilars | BiosimilarsCME.org | Online | Pharmacist |